Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jiangxi Xinganjiang Pharmaceutical CoBJSE:920367 70 Dividend Payout Ratio is 3.00 as of Jun. 2026, which is 598% above its 10-year median of 0.43. GuruFocus rates BJSE:920367 with a GF Score™ of 70/100 and a GF Value™ of ¥16.33 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 447 Drug Manufacturers companies, Jiangxi Xinganjiang Pharmaceutical Co ranks better than 77.4% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio for the
months ended in Jun. 2026 was 3.00.
BJSE:920367'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.18 Med: 0.43 Max: 0.71
Current: 0.18
During the past 10 years, the highest Dividend Payout Ratio of Jiangxi Xinganjiang Pharmaceutical Co was 0.71. The lowest was 0.18. And the median was 0.43.
BJSE:920367's Dividend Payout Ratio is ranked better than 77.4% of 447
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs BJSE:920367: 0.18
During the past 10 years, the highest Trailing Annual Dividend Yield of Jiangxi Xinganjiang Pharmaceutical Co was 3.02%. The lowest was 0.10%. And the median was 1.01%.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Payout Ratio Related Terms
Jiangxi Xinganjiang Pharmaceutical Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Payout Ratio Chart
BJSE:920367 vs ZTS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio falls into.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a Dividend Payout Ratio of 3.00 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. This is 598% above median its historical median of 0.43. Over the past decade, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.18 to 0.71. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #101 out of 447 companies in the Drug Manufacturers industry, placing it in the top 22.6%.
Is Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio too high?
Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Payout Ratio of 3.00 is 598% above median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.71. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Jiangxi Xinganjiang Pharmaceutical Co's value of 3.00 is 689.5% above this industry median. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #101 out of 447 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #101 out of 447 companies for Dividend Payout Ratio. This places Jiangxi Xinganjiang Pharmaceutical Co in the top 23% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Jiangxi Xinganjiang Pharmaceutical Co's value of 3.00 is 689.5% above this benchmark. Historically, Jiangxi Xinganjiang Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.18 to 0.71 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 0.38, Jiangxi Xinganjiang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 447 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Payout Ratio of 3.00 is 689.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Payout Ratio is 3.00, which is 598% above median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥16.33, compared to a current price of ¥28.21 — trading 72.7% above its estimated fair value. The current Dividend Payout Ratio is 3.00, which is 598% above median its 10-year median of 0.43 and 689.5% above the Drug Manufacturers industry median of 0.38. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current Dividend Payout Ratio is 3.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥28.21 is trading 72.7% above its estimated GF Value™ of ¥16.33.
GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for BJSE:920367:
Dividend Payout Ratio: 3.00 (598% above median its 10-year median of 0.43)
GF Value™: ¥16.33 vs. price of ¥28.21 (72.7% above fair value)
Industry Position: 689.5% above the Drug Manufacturers median (#101 of 447)
No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
70GF Score
Get the complete analysis for BJSE:920367
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920367 has been successfully added to your 
